December 18, 2015

Regeneron Pharmaceuticals v. Merus N.V.

View recent docket activity


Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.


Coverage

  1. October 2, 2017

    IP Attys Back Regeneron Over Inequitable Conduct Finding

    Numerous intellectual property law organizations and lawyers are calling for the full Federal Circuit to review its panel decision affirming that a Regeneron Pharmaceuticals Inc. patent is unenforceable in part because of inequitable conduct of litigators during a later infringement case, arguing it could “seriously and negatively affect the course of patent prosecution.”

3 other articles on this case. View all »

Parties

To view the parties, register now.